We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Gene and Cell Therapy – Products

A close up of an individual placing samples in the PCR machine.
Product News

Revvity Launches EONIS Q System Enabling Faster, Simplified Newborn Screening for SMA and SCID

Innovative, easy-to-use molecular diagnostics workflow reduces complexity and costs for labs looking to expand newborn screening capabilities.
Novel CAR Technology To Transform Cancer Therapy
Whitepaper

Novel CAR Technology To Transform Cancer Therapy

Chimeric antigen receptor (CAR) therapies involve the use of engineered receptors capable of redirecting immune cells to recognize and destroy cancer cells expressing a specific antigen. Currently, CAR T cells dominate the field of CAR therapy.
iPSCs To Accelerate Gene and Cell Product Development
Whitepaper

iPSCs To Accelerate Cell and Gene Product Development

These whitepapers highlight how optimized CRISPR protocols and site-specific knock-in technology can be used to engineer simple or complex genetic modifications in allogenic iPSCs.

A scientist holding a rack of biosamples.
Product News

Cytiva and RoosterBio Collaborate To Address Exosome Manufacturing Challenges

Aiming to improve exosome purification process that is currently slowing adoption of promising gene therapies and other new modalities.
Double helix structure of DNA with a section separated held by tweezers.
Product News

Broken String Biosciences’ Induce-Seq Platform Demonstrates Impact of Structural DNA Changes on Specificity of CRISPR-Cas9 Gene Editing

Research published in Molecular Cell used INDUCE-seq to identify DNA topology as an important regulator of CRISPR targeting specificity. Peer-reviewed data demonstrates the sensitivity of INDUCE-seq DNA break mapping platform.
Double helix structure of DNA with a piece cut out.
Product News

Integrated DNA Technologies Opens New Therapeutic Manufacturing Facility

Expanded footprint, new capabilities mark IDT’s entrance into CRISPR therapeutics space.
A scientist pipetting into an Eppendorf tube.
Product News

New Mid-Term Guidance 2024 – 2028 Supported by Ramp-Up of Growth Projects

At its Capital Markets Day in Visp (CH), Lonza shared a detailed update on its strategic priorities and provided new Mid-Term Guidance for 2024 to 2028.
The Advanced Flow Cytometry Handbook.
Product News

New Sartorius Digital Handbook Brings the Power of Advanced Flow Cytometry to Every Scientist

Sartorius, has released its first Advanced Flow Cytometry Handbook as a comprehensive digital guide to assays and workflows on the iQue® Advanced High Throughput Flow Cytometry Platform.
Unlocking the Potential of Cancer Immunotherapy with 3D Immune Cell Killing Assays
Whitepaper

Unlocking the Potential of Cancer Immunotherapy with 3D Immune Cell Killing Assays

This literature review explores the latest in 3D immune cell killing assays for cancer immunotherapy research.
A lab worker pipetting into an agar dish.
Product News

Takara Bio enters into a license agreement of RetroNectin® with Fondazione Telethon ETS

Takara Bio Inc. announces that it has entered into a License Agreement with non-profit/charity organization, Fondazione Telethon ETS Italy, under which Takara Bio grants Telethon a commercial license to use RetroNectin®.
Advertisement